Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells

Andra L. Blomkalns, Lynn L. Stoll, Wassim Shaheen, Sara A. Romig-Martin, Eric W. Dickson, Neal L. Weintraub, Gerene M. Denning

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Bacterial endotoxin, long recognized as a potent pro-inflammatory mediator in acute infectious processes, has more recently been identified as a risk factor for atherosclerosis and other cardiovascular diseases. When endotoxin enters the bloodstream, one of the first cells activated is the circulating monocyte, which exhibits a wide range of pro-inflammatory responses. Methods. We studied the effect of low doses of E. coli LPS on IL-8 release and superoxide formation by freshly isolated human peripheral blood mononuclear cells (PBMC). Results: IL-8 release was consistently detectable at 10 pg/ml of endotoxin, reaching a maximum at 1 ng/ml, and was exclusively produced by monocytes; the lymphocytes neither produced IL-8, nor affected monocyte IL-8 release. Superoxide production was detectable at 30 pg/ml of endotoxin, reaching a maximum at 3 ng/ml. Peak respiratory burst activity was seen at 15-20 min, and superoxide levels returned to baseline by 1 h. IL-8 release was dependent on both membrane-associated CD14 (mCD14) and Toll-like receptor 4 (TLR4. Superoxide production was dependent on the presence of LBP, but was not significantly affected by a blocking antibody to TLR4. Moreover, treatment with lovastatin inhibited LPS-dependent IL-8 release and superoxide production. Conclusions: These findings suggest that IL-8 release and the respiratory burst are regulated by distinct endotoxin-dependent signaling pathways in PBMC in low level of endotoxin exposure. Selectively modulating these pathways could lead to new approaches to treat chronic inflammatory diseases, such as atherosclerosis, while preserving the capacity of monocytes to respond to acute bacterial infections.

Original languageEnglish (US)
Article number4
JournalJournal of Inflammation
Volume8
DOIs
StatePublished - Mar 1 2011

Fingerprint

Interleukin-8
Endotoxins
Blood Cells
Blood
Superoxides
Monocytes
Respiratory Burst
Atherosclerosis
Lovastatin
Toll-Like Receptor 4
Blocking Antibodies
Lymphocytes
Bacterial Infections
Escherichia coli
Chronic Disease
Cardiovascular Diseases
Membranes

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology

Cite this

Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells. / Blomkalns, Andra L.; Stoll, Lynn L.; Shaheen, Wassim; Romig-Martin, Sara A.; Dickson, Eric W.; Weintraub, Neal L.; Denning, Gerene M.

In: Journal of Inflammation, Vol. 8, 4, 01.03.2011.

Research output: Contribution to journalArticle

Blomkalns, Andra L. ; Stoll, Lynn L. ; Shaheen, Wassim ; Romig-Martin, Sara A. ; Dickson, Eric W. ; Weintraub, Neal L. ; Denning, Gerene M. / Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells. In: Journal of Inflammation. 2011 ; Vol. 8.
@article{0fb9b1fc523845248711afac38554bad,
title = "Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells",
abstract = "Background: Bacterial endotoxin, long recognized as a potent pro-inflammatory mediator in acute infectious processes, has more recently been identified as a risk factor for atherosclerosis and other cardiovascular diseases. When endotoxin enters the bloodstream, one of the first cells activated is the circulating monocyte, which exhibits a wide range of pro-inflammatory responses. Methods. We studied the effect of low doses of E. coli LPS on IL-8 release and superoxide formation by freshly isolated human peripheral blood mononuclear cells (PBMC). Results: IL-8 release was consistently detectable at 10 pg/ml of endotoxin, reaching a maximum at 1 ng/ml, and was exclusively produced by monocytes; the lymphocytes neither produced IL-8, nor affected monocyte IL-8 release. Superoxide production was detectable at 30 pg/ml of endotoxin, reaching a maximum at 3 ng/ml. Peak respiratory burst activity was seen at 15-20 min, and superoxide levels returned to baseline by 1 h. IL-8 release was dependent on both membrane-associated CD14 (mCD14) and Toll-like receptor 4 (TLR4. Superoxide production was dependent on the presence of LBP, but was not significantly affected by a blocking antibody to TLR4. Moreover, treatment with lovastatin inhibited LPS-dependent IL-8 release and superoxide production. Conclusions: These findings suggest that IL-8 release and the respiratory burst are regulated by distinct endotoxin-dependent signaling pathways in PBMC in low level of endotoxin exposure. Selectively modulating these pathways could lead to new approaches to treat chronic inflammatory diseases, such as atherosclerosis, while preserving the capacity of monocytes to respond to acute bacterial infections.",
author = "Blomkalns, {Andra L.} and Stoll, {Lynn L.} and Wassim Shaheen and Romig-Martin, {Sara A.} and Dickson, {Eric W.} and Weintraub, {Neal L.} and Denning, {Gerene M.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1186/1476-9255-8-4",
language = "English (US)",
volume = "8",
journal = "Journal of Inflammation",
issn = "1476-9255",
publisher = "Springer Nature",

}

TY - JOUR

T1 - Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cells

AU - Blomkalns, Andra L.

AU - Stoll, Lynn L.

AU - Shaheen, Wassim

AU - Romig-Martin, Sara A.

AU - Dickson, Eric W.

AU - Weintraub, Neal L.

AU - Denning, Gerene M.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Background: Bacterial endotoxin, long recognized as a potent pro-inflammatory mediator in acute infectious processes, has more recently been identified as a risk factor for atherosclerosis and other cardiovascular diseases. When endotoxin enters the bloodstream, one of the first cells activated is the circulating monocyte, which exhibits a wide range of pro-inflammatory responses. Methods. We studied the effect of low doses of E. coli LPS on IL-8 release and superoxide formation by freshly isolated human peripheral blood mononuclear cells (PBMC). Results: IL-8 release was consistently detectable at 10 pg/ml of endotoxin, reaching a maximum at 1 ng/ml, and was exclusively produced by monocytes; the lymphocytes neither produced IL-8, nor affected monocyte IL-8 release. Superoxide production was detectable at 30 pg/ml of endotoxin, reaching a maximum at 3 ng/ml. Peak respiratory burst activity was seen at 15-20 min, and superoxide levels returned to baseline by 1 h. IL-8 release was dependent on both membrane-associated CD14 (mCD14) and Toll-like receptor 4 (TLR4. Superoxide production was dependent on the presence of LBP, but was not significantly affected by a blocking antibody to TLR4. Moreover, treatment with lovastatin inhibited LPS-dependent IL-8 release and superoxide production. Conclusions: These findings suggest that IL-8 release and the respiratory burst are regulated by distinct endotoxin-dependent signaling pathways in PBMC in low level of endotoxin exposure. Selectively modulating these pathways could lead to new approaches to treat chronic inflammatory diseases, such as atherosclerosis, while preserving the capacity of monocytes to respond to acute bacterial infections.

AB - Background: Bacterial endotoxin, long recognized as a potent pro-inflammatory mediator in acute infectious processes, has more recently been identified as a risk factor for atherosclerosis and other cardiovascular diseases. When endotoxin enters the bloodstream, one of the first cells activated is the circulating monocyte, which exhibits a wide range of pro-inflammatory responses. Methods. We studied the effect of low doses of E. coli LPS on IL-8 release and superoxide formation by freshly isolated human peripheral blood mononuclear cells (PBMC). Results: IL-8 release was consistently detectable at 10 pg/ml of endotoxin, reaching a maximum at 1 ng/ml, and was exclusively produced by monocytes; the lymphocytes neither produced IL-8, nor affected monocyte IL-8 release. Superoxide production was detectable at 30 pg/ml of endotoxin, reaching a maximum at 3 ng/ml. Peak respiratory burst activity was seen at 15-20 min, and superoxide levels returned to baseline by 1 h. IL-8 release was dependent on both membrane-associated CD14 (mCD14) and Toll-like receptor 4 (TLR4. Superoxide production was dependent on the presence of LBP, but was not significantly affected by a blocking antibody to TLR4. Moreover, treatment with lovastatin inhibited LPS-dependent IL-8 release and superoxide production. Conclusions: These findings suggest that IL-8 release and the respiratory burst are regulated by distinct endotoxin-dependent signaling pathways in PBMC in low level of endotoxin exposure. Selectively modulating these pathways could lead to new approaches to treat chronic inflammatory diseases, such as atherosclerosis, while preserving the capacity of monocytes to respond to acute bacterial infections.

UR - http://www.scopus.com/inward/record.url?scp=79951951856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951951856&partnerID=8YFLogxK

U2 - 10.1186/1476-9255-8-4

DO - 10.1186/1476-9255-8-4

M3 - Article

C2 - 21352551

AN - SCOPUS:79951951856

VL - 8

JO - Journal of Inflammation

JF - Journal of Inflammation

SN - 1476-9255

M1 - 4

ER -